Proposed Revisions to NIH Grant Review and Funding Raise Alarms Among Researchers and Advocates
Proposed changes to how grants are reviewed and funded by the National Institutes of Health (NIH), spearheaded by the Office of Management and Budget (OMB), are sparking significant concern among researchers, clinicians, and patient advocates. The proposed revisions, detailed in a recent OMB directive, are seen by many as a fundamental threat to the integrity of scientific inquiry and its ability to advance public health. Experts warn that these changes could stifle innovation, politicize research priorities, and ultimately harm patients by limiting the evidence base for medical practice.
The GeriPal Podcast, a platform for discussions on geriatrics and palliative care, recently convened an emergency session to address these developments. Hosts Eric Widera and Alex Smith were joined by prominent figures in the field: Dr. Stacy Fischer, a geriatrician, palliative care physician, researcher, and Science Advisor for the American Academy of Hospice and Palliative Medicine; Dr. Sean Morrison, Chair of the Department of Geriatrics and Palliative Medicine at the Icahn School of Medicine at Mount Sinai; and Dr. Ken Covinsky, a researcher in the UCSF Division of Geriatrics. Their collective expertise highlights a broad spectrum of anxieties regarding the proposed policy shifts.
Core Concerns Over Proposed NIH Policy Changes
At the heart of the controversy is the proposed shift in how research proposals are evaluated and approved. Historically, the NIH has operated on a system of rigorous peer review, where scientific merit, innovation, and potential impact on public health are the primary drivers of funding decisions. However, the new directives suggest that grants may need to align with the policy priorities of the executive government and could be subject to approval by political appointees.
Dr. Sean Morrison articulated this concern vividly, likening the ascent through the NIH funding process to an elevator ride. He warned that the proposed changes could lead to a politicization of science, where research deemed politically inconvenient, regardless of its scientific merit or potential to benefit patients, might be sidelined. This includes research focused on marginalized populations, health disparities, and inequities, areas that have historically benefited from NIH support.
"If we are going to judge science through a political lens, we are going to miss studying things that are important to our patients and our families," Dr. Morrison stated. He highlighted that geriatrics and palliative care, once fringe areas, gained mainstream prominence and funding through NIH support. The risk now, he explained, is that these fields could be neglected if they do not align with the current administration’s priorities.
One of the most alarming aspects of the proposed revisions, according to Dr. Stacy Fischer, is the potential for grants to be canceled at any time if they no longer align with institutional or governmental priorities. This raises ethical concerns, particularly for research involving patients who volunteer their time and personal data with the expectation that their contributions will lead to meaningful advancements.
"If a clinical trial is stopped midway because it no longer aligns with the institution’s priorities, that gift of their information, of their time that may be precious and limited is gone. It is wasted. It is, I think, really unethical and immoral to do that to people who have signed a consent as part of a clinical trial, expecting that their sacrifices and their gifts will not go to change practice or to help us understand something meaningful," Dr. Fischer explained.
Dr. Ken Covinsky emphasized that medical research is fundamentally a public trust, intended to improve the lives of patients and their families. He argued that the proposed changes invert this principle, suggesting that research should serve the political interests of those in power rather than the needs of the public. "This is like fundamentally getting at the question of does research exist to help the needs and concerns of the public, or does research exist to help the needs of whichever politician is in power at the moment?" Dr. Covinsky questioned.
Erosion of Peer Review and International Collaboration
A significant point of contention is the perceived weakening of the peer review process. Dr. Fischer elaborated on how peer review traditionally ensures that grants are critiqued by experts in the field, identifying strengths and weaknesses to guarantee the best possible science. The introduction of political appointees into this decision-making process, she fears, could lead to arbitrary decisions based on factors unrelated to scientific rigor.
"When a political appointee can then come in and say yes or no based on maybe their own personal experience, maybe the administration’s priority, maybe because of some other kind of lobby or influence that is driving their decision, that upends that whole process," Dr. Fischer noted. The ripple effects, she believes, will be felt by patients and families, potentially setting back research progress by decades.
Dr. Sean Morrison drew a parallel to the early days of the AIDS epidemic. He pointed out that NIH’s independence allowed for funding of research on a then-unpopular disease affecting marginalized communities. This led to life-saving treatments that transformed HIV from a fatal diagnosis into a manageable chronic illness. He cautioned that such critical research might not have been funded if it had been subject to the political considerations now being proposed.
The proposed restrictions on international collaboration also drew sharp criticism. Dr. Morrison highlighted the critical role of global partnerships in advancing fields like dementia research, where large international biobanks are essential for understanding complex diseases. He expressed concern that prohibitions against collaborating with international scientists could severely hinder progress, particularly in areas requiring large-scale data collection and diverse populations.
Dr. Ken Covinsky provided a stark example, stating that collaboration with scientists in regions where viruses like Ebola exist is crucial for preventing their spread to the United States. Similarly, working with international colleagues on emerging infectious diseases is a matter of national security and public health preparedness.
Impact on Research Workforce and Innovation
Beyond the direct impact on research topics, experts are concerned about the long-term consequences for the scientific workforce. The proposed changes, including potential cuts to training grants and limitations on the number of grants a principal investigator can hold, could deter early-career scientists from pursuing research careers, particularly in fields like geriatrics and palliative care.
Dr. Stacy Fischer pointed out that these measures could lead to a "thinning out" of the scientific community, making it difficult for the field to attract and retain talent. Dr. Sean Morrison and Dr. Ken Covinsky acknowledged that while there might be a valid concern about the concentration of funding among senior investigators, the proposed solutions are overly simplistic and could have unintended negative consequences, such as hindering the support of junior researchers who rely on grants held by established PIs.
Dr. Alex Smith raised concerns about the potential ban on research related to Diversity, Equity, and Inclusion (DEI) and gender studies. While acknowledging that there are legitimate debates about the implementation of DEI initiatives, he argued that a complete ban on such research is a "terrible idea" that would silence entire areas of inquiry and erase vulnerable populations from scientific consideration. He stressed the importance of understanding structural racism and its impact on health, as well as acknowledging diverse gender identities, for robust health services research.
Dr. Ken Covinsky echoed this sentiment, suggesting that the attack on DEI has been used as a pretext to dismiss "inconvenient truths" that are fact-based and essential for understanding public health. He emphasized that acknowledging the impact of social determinants on health is not a political stance but a scientific reality.
Publication Fees and Censorship Concerns
Another critical issue highlighted is the proposed restriction on using grant funds to cover publication fees for open-access articles. The NIH has recently mandated that research it funds be made publicly accessible, a move generally supported by the scientific community. However, the proposed rule that grant money cannot be used for these fees creates a significant dilemma, as journals often charge substantial fees for immediate open-access publication.
Dr. Stacy Fischer described this as a "conundrum" that could effectively gag researchers, preventing them from sharing their findings with the wider scientific and clinical community in a timely manner. She noted that publication fees can range from thousands to tens of thousands of dollars, posing a particular challenge for junior researchers who may not have alternative funding sources.
Dr. Sean Morrison voiced a particularly chilling concern: the possibility that researchers might need political approval to discuss their NIH-funded work. This, he argued, amounts to de facto censorship, undermining the core principle of disseminating scientific knowledge to the public.
Call to Action
Given the gravity of these proposed changes, the GeriPal podcast hosts and their guests urged listeners to take action. The public comment period for the proposed revisions is open until mid-July, and experts emphasize the importance of submitting personalized comments.
"It’s really important to personalize it. Talk about the patients you care for, talk about how science has helped you care for them and make it personal. Tell them why it affects you and how it’s going to affect your patients," advised Dr. Sean Morrison.
Dr. Ken Covinsky encouraged listeners to articulate their desire for research to focus on improving health outcomes rather than serving political interests. He suggested describing specific health issues that affect them or their loved ones and advocating for research to address those needs.
Dr. Stacy Fischer stressed that the sheer volume of public comments can influence policy decisions. She also highlighted the importance of contacting elected officials, including representatives and senators, to voice concerns, as some of these changes may already be subtly implemented at NIH.
The discussion concluded with a powerful rendition of Bob Dylan’s "The Times They Are a-Changin’," a fitting soundtrack to a moment of significant potential upheaval in the landscape of scientific funding and research. The experts’ overarching message was clear: the proposed revisions to NIH grant policies pose a serious threat to scientific progress and patient well-being, and active engagement from the public and the scientific community is crucial to safeguard the future of medical research. Links to relevant resources for submitting comments and learning more will be provided in the show notes of the GeriPal Podcast episode.
